Back

Temporal trends in antithrombotic therapy following transcatheter aortic valve implantation in denmark

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Prosthetic heart valves: preventing thrombosis and stroke Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Ms Helene Vistisen

Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Association between silent cerebral embolism and cognitive alterations following transcatheter aortic valve replacement in bicuspid versus tricuspid aortic valve patients
Doctor Y. Huang (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of the ultraslow low-dose thrombolytic regimen for mechanical prosthetic valve thrombosis: a prospective cohort study
Professor P. Sadeghipour (Tehran, IR)
Abstract Slides Video
Presentation thumbnail
Anticoagulation control challenges in patients with rheumatic heart disease and mechanical heart valves operated at a cardiac surgery center in a low-income country
Mrs C. Nhavoto (Maputo, MZ)
Abstract Slides Video
Presentation thumbnail
Surgery versus thrombolytic therapy for the management of left-sided prosthetic valve thrombosis without hemodynamic compromise: a systematic review and meta-analysis
Doctor R. Chopard (Besancon, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Prosthetic heart valves: preventing thrombosis and stroke

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Nationwide observational study of antithrombotic treatment strategies after coronary artery bypass graft surgery in patients with atrial fibrillation
thumbnail
Congress Presentation
Implementation of new antithrombotic treatment strategies and outcome improvements in patients with myocardial infarction and atrial fibrillation over 20 years: a nationwide cohort study
thumbnail
Congress Presentation
Bleeding risk in all-comer TAVI patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources